The FDA announced that it cleared the Visibly Digital Acuity Product, a web-based, self-guided software application for testing visual acuity at home. The technology, which the FDA cleared Aug. 12, is ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Online eyewear and vision care company Visibly announced it had received FDA 510(k) clearance for its at-home vision test. The Visibly Digital Acuity Product uses a touchscreen mobile device, like a ...
Please provide your email address to receive an email when new articles are posted on . “We are excited to be developing a simple test that clinicians can use to estimate the level of vision in ...
Credit: Shutterstock. Individuals can complete the test in approximately 6 minutes, at which point the test results will be made available to an eye care professional. The Food and Drug Administration ...
Caring for your eyes and vision are important parts of a healthy lifestyle. Vision screening is a simple test of your vision that can detect problems early. An eye exam is a detailed check of your ...
A smartphone-based test for visual acuity is as accurate and repeatable as currently available standard visual acuity tests, according to a new study published online May 28 in JAMA Ophthalmology. The ...
(HealthDay News) — A computerized visual acuity-based screening program that employs a rapid, age-specific standardized algorithm is effective and practical for screening 3- to 7-year-old children, ...
Resolving naked-eye double stars presents an unusual visual challenge. To see fine detail, we usually look directly at the object of study so that light falls onto the eye’s fovea centralis — the pit ...
The purpose of this study was to evaluate the discrepancy between the near visual acuity (VA) measurements using the EyeHandBook smartphone application and the ...
Visual acuity --- the ability to see objects in sharp detail --- was evaluated in 1,504 children aged 30 to 71 months as part of the Baltimore Pediatric Eye Disease Study, the first large, ...